Mark E. Drotar
Impact in
- Aging top 10%
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Immune Cell Function and Interaction 3
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Tony McBryan (2 shared papers)Peter D. Adams (2 shared papers)John van Tuyn (2 shared papers)Peter Burke (2 shared papers)Joanna B. Wilson (5 shared papers)Robert Armour Forse (2 shared papers)Penelope M. Tsimbouri (4 shared papers)Nathan D. VanderKraats (1 shared paper)
- Journals
- Oncogene (2 papers)Journal of General Virology (1 paper)Nature (1 paper)International Journal of Cancer (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomUnited StatesSaudi Arabia
In The Last Decade
Mark E. Drotar
12 papers receiving 827 citations
Peers
Comparison fields: 5 of 72
- Aging 34
- Hematology 149
- Genetics 89
- Immunology 163
- Oncology 199
Countries citing papers authored by Mark E. Drotar
This map shows the geographic impact of Mark E. Drotar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Drotar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Drotar more than expected).
Fields of papers citing papers by Mark E. Drotar
This network shows the impact of papers produced by Mark E. Drotar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Drotar. The network helps show where Mark E. Drotar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Drotar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 284 | |
| 2 | 2016 | 182 | |
| 3 | Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. | 1995 | 90 |
| 4 | 2016 | 60 | |
| 5 | 2013 | 57 | |
| 6 | 2002 | 55 | |
| 7 | 2003 | 31 | |
| 8 | 2018 | 30 | |
| 9 | Rapid modulation of liver-specific transcription factors after injury. | 1994 | 26 |
| 10 | 2024 | 10 | |
| 11 | 2008 | 7 | |
| 12 | 2003 | 5 |
About Mark E. Drotar
Mark E. Drotar is a scholar working on Immunology, Pathology and Forensic Medicine, Oncology, Hematology and Genetics, having authored 12 papers that have together received 837 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (4 papers), Immune Cell Function and Interaction (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Genomics and Chromatin Dynamics (2 papers) and Animal Genetics and Reproduction (1 paper). The work is most often cited by research in Aging (34 citations), Hematology (149 citations), Genetics (89 citations), Immunology (163 citations) and Oncology (199 citations). Mark E. Drotar has collaborated with scholars based in United Kingdom, United States and Saudi Arabia. Frequent co-authors include Tony McBryan, Peter D. Adams, John van Tuyn, Peter Burke, Joanna B. Wilson, Robert Armour Forse, Penelope M. Tsimbouri, Nathan D. VanderKraats, Claire Brock and Richard R. Meehan. Their work appears in journals such as Oncogene, Journal of General Virology, Nature, International Journal of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.